×
Displaying 40 - 50 of 72
First
«
3
4
5
6
7
»
Last
Targeted EGFR/HER2 Therapy to Overcome the Blood-Brain Barrier
Targeted EGFR/HER2 Therapy to Overcome the Blood-Brain Barrier
Defining Mechanisms of Resistance to KRASG12C Inhibitors
Defining Mechanisms of Resistance to KRASG12C Inhibitors
Mechanisms of Resistance to Endocrine Therapy and CDK4/6 Inhibitors in ER+ Breast Cancer
Mechanisms of Resistance to Endocrine Therapy and CDK4/6 Inhibitors in ER+ Breast Cancer
Meet the Editors Roundtable
Meet the Editors Roundtable
Driving Precision Medicine through Clinical Computational Oncology
Driving Precision Medicine through Clinical Computational Oncology
Emerging Technologies II
Emerging Technologies II
Organotypic Modeling of Cancer and Immune Cell Dynamics
Organotypic Modeling of Cancer and Immune Cell Dynamics
Inferring and Making Sense Out of Cancer Cell Phylogenies
Inferring and Making Sense Out of Cancer Cell Phylogenies
Targeted Protein Degradation- A New Approach for Challenging Targets
Targeted Protein Degradation- A New Approach for Challenging Targets
Short Talk: MLL-Menin Inhibition Reverses Pre-leukemic Progenitor Self-renewal in NPM1 Mutant AML
Short Talk: MLL-Menin Inhibition Reverses Pre-leukemic Progenitor Self-renewal in NPM1 Mutant AML
Displaying 40 - 50 of 72
First
«
3
4
5
6
7
»
Last
×
Evaluation